Chris Sander
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Monoclonal and Polyclonal Antibodies Research
Strong evidence · 3 supporting papers · latest 2026
Protein Degradation and Inhibitors
Strong evidence · 2 supporting papers · latest 2025
Ubiquitin and proteasome pathways
Strong evidence · 2 supporting papers · latest 2025
Advanced Proteomics Techniques and Applications
Strong evidence · 3 supporting papers · latest 2026
Single-cell and spatial transcriptomics
Strong evidence · 2 supporting papers · latest 2026
Cell Image Analysis Techniques
Strong evidence · 1 supporting paper · latest 2026
Cellular Mechanics and Interactions
Strong evidence · 1 supporting paper · latest 2026
Advanced Fluorescence Microscopy Techniques
Strong evidence · 1 supporting paper · latest 2026
Publications (17)
Design of combination therapeutics from protein response to drugs in ovarian cancer cells
2025DOI
Design of combination therapeutics from protein response to drugs in ovarian cancer cells
2025DOI
Data modeling the interplay between single-cell shape, single-cell protein expression, and tissue state
2026DOIPMID 42143015
AI proteomics: from protein identification to virtual cells
2026DOIPMID 42521824
Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
2025DOI
Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
2026DOI
Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
2026DOI
evedesign: accessible biosequence design with a unified framework
2026DOI
The 2025 Westlake Autumn Symposium for AI Proteomics and Virtual Cell
2026DOIPMID 41795813
Reviewer #3 (Public review): Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
2026DOI
Reviewer #1 (Public review): Design of combination therapeutics from protein response to drugs in ovarian cancer cells
2026DOI
Reviewer #2 (Public review): Design of combination therapeutics from protein response to drugs in ovarian cancer cells
2026DOI
Author response: Design of combination therapeutics from protein response to drugs in ovarian cancer cells
2026DOI
Identifying cohorts at elevated risk of cancers using generative modeling of patient health states
2026DOI
Reviewer #2 (Public review): Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27